Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 2/20 | 0.56 |
| ▸ | USP2 | O75604 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.53 |
| ▸ | DNASE1L3 | Q13609 | 1/20 | 0.51 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.51 |
| ▸ | HTRA2 | O43464 | 3/20 | 0.51 |
| ▸ | HTRA1 | Q92743 | 3/20 | 0.51 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ALPL | P05186 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | ALPI | P09923 | 1/20 | 0.48 |
| ▸ | ALPG | P10696 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24943216 | 0.95 | USP2 (0.58) | ALBUSP2L3MBTL1FOLH1CA9 | |
| SCHEMBL24943218 | 0.88 | ALB (0.59) | ALBUSP2L3MBTL1FOLH1DNASE1L3 | |
| SCHEMBL13286956 | 0.87 | ALB (0.60) | ALBUSP2L3MBTL1FOLH1DNASE1L3 | |
| SCHEMBL12123525 | 0.87 | ALB (0.60) | ALBUSP2L3MBTL1FOLH1DNASE1L3 | |
| SCHEMBL15298994 | 0.86 | USP2 (0.58) | ALBUSP2L3MBTL1FOLH1DNASE1L3 | |
| SCHEMBL30153542 | 0.86 | USP2 (0.52) | ALBUSP2L3MBTL1FOLH1DNASE1L3 | |
| SCHEMBL24062674 | 0.86 | ALB (0.59) | ALBUSP2L3MBTL1FOLH1DNASE1L3 | |
| SCHEMBL24943566 | 0.86 | ALB (0.61) | ALBUSP2L3MBTL1FOLH1DNASE1L3 | |
| SCHEMBL18211595 | 0.86 | ALB (0.59) | ALBUSP2L3MBTL1FOLH1DNASE1L3 | |
| SCHEMBL18162919 | 0.86 | ALB (0.59) | ALBUSP2L3MBTL1FOLH1DNASE1L3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023006909-A1 | FUNCTIONALISATION OF CARBOXYMETHYLCELLULOSE | THE UNIVERSITY OF MANCHESTER (GB) | 2023-02-02 | — | — | WO | disclosed |
| US-20210030882-A1 | USE OF BIS-IMINOBIOTIN COMPOUND FOR DRUG DELIVERY PURPOSES | MITSUI CHEMICALS, INC. (JP) | 2021-02-04 | — | — | US | disclosed |
| WO-2019189867-A1 | USE OF BIS-IMINOBIOTIN COMPOUND FOR DRUG DELIVERY PURPOSES | 三井化学株式会社 | 2019-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210030882-A1 | USE OF BIS-IMINOBIOTIN COMPOUND FOR DRUG DELIVERY PURPOSES | BTD, PAICS, BRD9 | ALB 416/4885USP2 4400/4885L3MBTL1 3063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.